The State of Dermatology 2025: An ARTO Industry Report

Navigating Growth, Innovation, and Talent in the Dermatology Sector

The dermatology industry is undergoing a transformation, driven by cutting-edge treatments, AI-powered diagnostics, and a surge in investment. With over $195 billion invested in the field since 2015 and a 160% increase in FDA-approved dermatologic drugs, the sector is booming. But what does this mean for investors, pharmaceutical companies, and healthcare professionals?

In this exclusive report, ARTO provides deep insights into the key trends shaping dermatology in 2025. From talent movements to market shifts, discover the forces driving one of the fastest-growing sectors in healthcare.

Download the report to explore:

• Market Momentum – The dermatology sector is valued at $190 billion and growing at 11–13% CAGR, fueled by AI diagnostics and regenerative medicine.

• Investment & M&A Trends – Over $9 billion in venture capital has flowed into dermatology startups since 2011, with private equity consolidating major practice groups.

• Breakthrough Treatments – 50+ new dermatology drugs have been approved globally since 2015, transforming patient care with biologics, immunotherapies, and AI-driven solutions.

• Industry Leaders – Pharma giants like AbbVie, Novartis, and Pfizer continue to dominate, while new players are shaping the landscape.

• Talent Shifts & Hiring Trends – Demand is rising for AI dermatopathologists, biotech innovators, and CRISPR scientists, with executive leadership in high demand.

Whether you’re an investor, biotech leader, or healthcare professional, this report provides the insights you need to navigate the evolving dermatology industry.